Skip to main content

Erratum to: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation

Abstract

No abstract

Correction

After the publication of this work [1], we became aware that it contains inaccurate description. The correct description on page 5 was “At every timepoint, statistically significant differences were observed between IM olanzapine and IM placebo groups (p < .01) (Figure one)”, and not “At every timepoint, statistically significant differences were observed between IM olanzapine and IM placebo groups (p < .001) (Figure one).” We regret any inconvenience that this inaccuracy might have caused.

References

  1. 1.

    Katagiri H, Fujikoshi S, Suzuki T, Fujita K, Sugiyama N, Takahashi M, Gomez JC: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation. BMC Psychiatry. 2013, 13: 20-10.1186/1471-244X-13-20.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hideaki Katagiri.

Additional information

The online version of the original article can be found at 10.1186/1471-244X-13-20

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Katagiri, H., Fujikoshi, S., Suzuki, T. et al. Erratum to: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation. BMC Psychiatry 14, 313 (2014). https://doi.org/10.1186/s12888-014-0313-9

Download citation